LRP5 Protein - LDL Receptor-Related Protein 5

LRP5 Protein - LDL Receptor-Related Protein 5

Introduction

Lrp5 Protein Ldl Receptor Related Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@lrp2019]
<table> [@structure2020]
<tr><th colspan="2" style="background:#f0f0f0;">LRP5 Protein</th></tr> [@lrp2018]
<tr><td><b>Protein Name</b></td><td>LDL Receptor-Related Protein 5</td></tr> [@wntcatenin2021]
<tr><td><b>Gene</b></td><td>LRP5</td></tr> [@lrp2020]
<tr><td><b>Category</b></td><td>Protein</td></tr> [@lrp2022]
<tr><td><b>Path</b></td><td>/proteins/lrp5-protein</td></tr> [@lrp2019a]
</table> [@wnt2020]
</div> [@lrp2018a]

Overview

LRP5 Protein - LDL Receptor-Related Protein 5

Introduction

Lrp5 Protein Ldl Receptor Related Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@lrp2019]
<table> [@structure2020]
<tr><th colspan="2" style="background:#f0f0f0;">LRP5 Protein</th></tr> [@lrp2018]
<tr><td><b>Protein Name</b></td><td>LDL Receptor-Related Protein 5</td></tr> [@wntcatenin2021]
<tr><td><b>Gene</b></td><td>LRP5</td></tr> [@lrp2020]
<tr><td><b>Category</b></td><td>Protein</td></tr> [@lrp2022]
<tr><td><b>Path</b></td><td>/proteins/lrp5-protein</td></tr> [@lrp2019a]
</table> [@wnt2020]
</div> [@lrp2018a]

Overview

LRP5 (Low-Density Lipoprotein Receptor-Related Protein 5) is a transmembrane receptor protein that plays critical roles in Wnt signaling, bone metabolism, and cholesterol homeostasis. As a co-receptor for Wnt ligands, LRP5 is essential for activating canonical Wnt/β-catenin signaling pathways that regulate embryonic development, adult tissue maintenance, and cellular functions in the brain. In the central nervous system, LRP5 is expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation), where it modulates synaptic plasticity, cognitive function, and neuroprotection. Genetic variants in LRP5 have been associated with altered risk for Alzheimer's disease, osteoporosis, and metabolic disorders, making it an important therapeutic target [1][2]. [@lrp2021a]

Structure

LRP5 is a large type I transmembrane protein consisting of 1615 amino acids with the following domain organization:

• N-terminal extracellular domain: Contains four β-propeller motifs followed by three low-density lipoprotein receptor (LDLR) type A domains. These propeller domains mediate interactions with Wnt ligands and antagonists including Dkk1 and sclerostin [3].
• Single transmembrane helix: Spans the cell membrane, anchoring the receptor complex.
• C-terminal cytoplasmic tail: Contains PPXY motifs that interact with β-catenin destruction complex components and facilitate downstream signaling.

Function

Wnt Signaling Co-receptor

LRP5 serves as a primary co-receptor for Wnt ligands in the canonical Wnt/β-catenin signaling pathway. Upon Wnt ligand binding to the LRP5-Frizzled receptor complex:

Target genes include:

• Cell cycle regulators (c-Myc, Cyclin D1)
• Osteogenic factors (Runx2, Osterix)
• Synaptic proteins (PSD-95, Synapsin)
• Anti-apoptotic proteins (Bcl-2, survivin) [5]

Bone Metabolism

In osteoblasts, LRP5 activates Wnt signaling to:

• Promote osteoblast differentiation and survival
• Enhance bone formation
• Regulate osteoclast activity through RANKL/OPG signaling

Cholesterol Metabolism

LRP5 influences lipid metabolism by:

• Regulating intestinal cholesterol absorption
• Modulating hepatic lipid homeostasis
• Influencing circulating LDL cholesterol levels

CNS Functions

In the brain, LRP5 modulates:

• Synaptic plasticity: Regulates [NMDA receptor](/entities/nmda-receptor) trafficking and [long-term potentiation](/mechanisms/long-term-potentiation) (LTP)
• Cognitive function: Mouse models show impaired learning and memory with LRP5 deficiency
• Neuroprotection: Activates anti-apoptotic pathways and reduces oxidative stress
• Microglial function: Influences inflammatory responses in neurodegenerative contexts [7]

Role in Disease

Alzheimer's Disease

LRP5 plays a complex role in Alzheimer's disease pathogenesis:

Amyloid-β metabolism: LRP5 affects [amyloid precursor protein](/entities/app-protein) (APP) processing through Wnt signaling modulation. Reduced LRP5 function may increase [β-secretase](/entities/bace1) (BACE1) activity, enhancing amyloidogenic APP cleavage [8].

[Tau](/proteins/tau) pathology: Wnt/β-catenin signaling normally suppresses GSK3β activity. LRP5 dysfunction may contribute to tau hyperphosphorylation through disinhibition of GSK3β [9].

Synaptic failure: LRP5 deficiency in neurons leads to:

• Reduced synaptic density
• Impaired LTP
• Decreased PSD-95 and Synapsin expression
• Memory deficits in mouse models

• Late-onset Alzheimer's disease risk
• Age of onset modification
• Response to [cholinesterase inhibitors](/entities/cholinesterase-inhibitors) [10]

Osteoporosis-Pseudoglioma Syndrome (OPPG)

Autosomal recessive disorder caused by LRP5 loss-of-function mutations:

• Severe early-onset osteoporosis
• Blindness (pseudoglioma)
• Skeletal fragility
• Cognitive impairment in some cases

Other Neurological Conditions

• Parkinson's disease: LRP5 variants may modify disease risk; role in dopaminergic neuron survival studied
• Multiple sclerosis: LRP5 influences immune cell trafficking and demyelination
• Stroke: LRP5-mediated neuroprotection against ischemic injury investigated [11]

Therapeutic Targeting

Agonists

• Wnt ligands: Recombinant Wnt proteins or stabilizers
• Small molecules: GSK3β inhibitors ( lithium, tideglusib)
• LRP5-binding compounds: Antibody fragments targeting propeller domains

Antagonists

• Dkk1 inhibitors: Neutralizing antibodies (DKN-01 in clinical trials)
• Sclerostin antibodies: Romosozumab approved for osteoporosis; brain penetration being explored

Challenges

• Tissue-specific effects (bone vs. brain)
• Blood-brain barrier delivery
• Cancer risk with chronic Wnt activation
• Off-target effects on stem cell populations

Biomarkers

LRP5 as a biomarker:

• Genetic: LRP5 polymorphisms predict AD risk and treatment response
• Expression: LRP5 mRNA in blood or CSF as potential biomarker
• Functional: Wnt signaling assays in patient-derived cells

Background

The study of Lrp5 Protein Ldl Receptor Related Protein 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [LRP5 Gene](/proteins/lrp5)
• [Wnt Signaling Pathway in Neurodegeneration](/diseases/neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade)
• [GSK3Beta in Neurodegeneration](/diseases/neurodegeneration)